ASCO 2024

Article collection

We are proud to present a special collection of articles for the American Society of Clinical Oncology Annual Meeting 2024. This curated selection showcases the cutting-edge advancements and novel perspectives published in journals from Elsevier's Oncology Journal Network. We invite you to explore this collection and delve deeper into the exciting advancements shaping the future of cancer research.

Annals of Oncology

• Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 Wird in neuem Tab/Fenster geöffnet

• Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047] Wird in neuem Tab/Fenster geöffnet

Blood Neoplasia

• Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination Wird in neuem Tab/Fenster geöffnet

Cancer Epidemiology

• Risk factors for early-onset colorectal cancer: A Canadian prospective cohort study Wird in neuem Tab/Fenster geöffnet

• Metformin’s role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study Wird in neuem Tab/Fenster geöffnet

Cancer Letters

• Organoid: Bridging the gap between basic research and clinical practice Wird in neuem Tab/Fenster geöffnet

• SPOP-mutant prostate cancer: Translating fundamental biology into patient care Wird in neuem Tab/Fenster geöffnet

Cancer Pathogenesis and Therapy

• PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer Wird in neuem Tab/Fenster geöffnet

• Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus Wird in neuem Tab/Fenster geöffnet

• Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018) Wird in neuem Tab/Fenster geöffnet

Cancer Treatment Reviews

• Waiting for the “liquid revolution” in the adjuvant treatment of colon cancer patients: a review of ongoing trials Wird in neuem Tab/Fenster geöffnet

• First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States Wird in neuem Tab/Fenster geöffnet

Clinical Breast Cancer

• Unlocking the Power of the Homing Phenomenon: Why Breast Conserving Surgery Outshines Mastectomy in Overall Survival Wird in neuem Tab/Fenster geöffnet

• Robotics in Screening, Diagnosis and Treatment of Breast Cancer: A Perspective View Wird in neuem Tab/Fenster geöffnet

• Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics Wird in neuem Tab/Fenster geöffnet

Clinical Colorectal Cancer

• Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence Wird in neuem Tab/Fenster geöffnet

• Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review Wird in neuem Tab/Fenster geöffnet

• A Case of Heavily Pretreated HER2+ Colorectal Liver Metastases Responsive to Hepatic Arterial Infusion Chemotherapy Wird in neuem Tab/Fenster geöffnet

Clinical Genitourinary Cancer

• Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy Wird in neuem Tab/Fenster geöffnet

• Cystic Pelvic Masses in Men: A Presentation of Uncommon Cases and a Literature Review Wird in neuem Tab/Fenster geöffnet

• The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence Wird in neuem Tab/Fenster geöffnet

Clinical Lung Cancer

• Lung Cancer in Women: The Past, Present, and Future Wird in neuem Tab/Fenster geöffnet

• Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challenges Wird in neuem Tab/Fenster geöffnet

• Personalised Assessment and Rapid Intervention in Frail Patients With Lung Cancer: The Impact of an Outpatient Occupational Therapy Service Wird in neuem Tab/Fenster geöffnet

Clinical Lymphoma Myeloma and Leukemia

• Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma Wird in neuem Tab/Fenster geöffnet

• Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial Wird in neuem Tab/Fenster geöffnet

• Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable Wird in neuem Tab/Fenster geöffnet

Clinics

• Delayed diagnosis and increased mortality risk: Assessing the effects of the COVID-19 pandemic on breast cancer recurrence Wird in neuem Tab/Fenster geöffnet

• Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapy Wird in neuem Tab/Fenster geöffnet

• Prolonged survival after thoracic metastasectomy in patients with nonseminomatous testicular cancer Wird in neuem Tab/Fenster geöffnet

Critical Reviews in Oncology/Hematology

• A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications Wird in neuem Tab/Fenster geöffnet

• Oncogenic fusions: Targeting NTRK Wird in neuem Tab/Fenster geöffnet

• Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics Wird in neuem Tab/Fenster geöffnet

ESMO Gastrointestinal Oncology

• Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK Wird in neuem Tab/Fenster geöffnet

• Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status Wird in neuem Tab/Fenster geöffnet

ESMO Open

• Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial Wird in neuem Tab/Fenster geöffnet

• Antibody–drug conjugates are active in patients with HER2-positive breast cancer brain metastases: where do we go from here? Wird in neuem Tab/Fenster geöffnet

ESMO Real World Data and Digital Oncology

• Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data Wird in neuem Tab/Fenster geöffnet

• Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC) Wird in neuem Tab/Fenster geöffnet

Gynecologic Oncology

• Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update Wird in neuem Tab/Fenster geöffnet

• Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis Wird in neuem Tab/Fenster geöffnet

• Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer Wird in neuem Tab/Fenster geöffnet

• A personalized probabilistic approach to ovarian cancer diagnostics Wird in neuem Tab/Fenster geöffnet

Gynecologic Oncology Reports

• Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansine Wird in neuem Tab/Fenster geöffnet

• The challenging journey of cervical cancer diagnosis and treatment at the second largest hospital in Indonesia Wird in neuem Tab/Fenster geöffnet

• Quality corner: Safely using cephalosporins in almost all patients with penicillin allergies: Mini-review and suggested protocol to improve efficacy and surgical outcomes Wird in neuem Tab/Fenster geöffnet

• Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directions Wird in neuem Tab/Fenster geöffnet

Immuno-Oncology and Technology

• Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: The phase 1 TRIBE trial Wird in neuem Tab/Fenster geöffnet

• Engineering approaches for innate immune-mediated tumor microenvironment remodeling Wird in neuem Tab/Fenster geöffnet

Journal of Cancer Policy

• Implications of FDA’s marketing authorization of hereditary cancer testing Wird in neuem Tab/Fenster geöffnet

• INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas Wird in neuem Tab/Fenster geöffnet

Journal of the National Cancer Center

• Cancer incidence and mortality in China, 2016 Wird in neuem Tab/Fenster geöffnet

• Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry data Wird in neuem Tab/Fenster geöffnet

• The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy Wird in neuem Tab/Fenster geöffnet

Journal of Thoracic Oncology

• Read here for the Journal of Thoracic Oncology ASCO articles. Wird in neuem Tab/Fenster geöffnet

Leukemia Research

• CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123 Wird in neuem Tab/Fenster geöffnet

• Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79b Wird in neuem Tab/Fenster geöffnet

• The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms Wird in neuem Tab/Fenster geöffnet

Leukemia Research Reports

• Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas Wird in neuem Tab/Fenster geöffnet

• Myeloid neoplasms in inflammatory bowel disease: A case series and review of the literature Wird in neuem Tab/Fenster geöffnet

• Long-term follow-up of efficacy and safety in elderly patients with chronic myeloid leukemia treated with intermittent low dose dasatinib therapy Wird in neuem Tab/Fenster geöffnet

Magnetic Resonance Imaging

• Delineation of the internal iliac vein using MRI with true FISP sequence in patients with locally recurrent rectal cancer: A pilot study using CT/MRI fusion Wird in neuem Tab/Fenster geöffnet

Neoplasia

• Interdisciplinary care of children with diffuse midline glioma Wird in neuem Tab/Fenster geöffnet

Oral Oncology

• HER2-targeted therapies for salivary gland cancers Wird in neuem Tab/Fenster geöffnet

• Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma Wird in neuem Tab/Fenster geöffnet

Oral Oncology Reports

• Salivary exosomes as biomarkers for early diagnosis of oral squamous cell carcinoma Wird in neuem Tab/Fenster geöffnet

Radiation Medicine and Protection

• Comparison of pencil beam and Monte Carlo calculations with ion chamber array measurements for patient-specific quality assurance Wird in neuem Tab/Fenster geöffnet

• Alzheimer's disease and low-dose radiation therapy: A new hope Wird in neuem Tab/Fenster geöffnet

• Expert consensus on radiotherapy combined with immunotherapy for esophageal cancer (2024 edition) Wird in neuem Tab/Fenster geöffnet

Seminars in Oncology

• PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics Wird in neuem Tab/Fenster geöffnet

• PARP inhibitors for prostate cancer Wird in neuem Tab/Fenster geöffnet

Surgical Oncology Insight

• The effect of the pandemic on colorectal cancer in the United States: an increased disease burden Wird in neuem Tab/Fenster geöffnet

• Assessing the OPRA Trial for surgical oncologists: Safety and feasibility of a total neoadjuvant therapy approach in patients with rectal cancer Wird in neuem Tab/Fenster geöffnet

• Malignant Bowel Obstruction: Historical Lessons, Current Trends, and Future Directions Wird in neuem Tab/Fenster geöffnet

• Implementation of the 2015 American Thyroid Association Guideline Changes Across a Health System: A Quality Improvement Opportunity Wird in neuem Tab/Fenster geöffnet

The Breast

• Platinum chemotherapy for early triple-negative breast cancer Wird in neuem Tab/Fenster geöffnet

• Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trial Wird in neuem Tab/Fenster geöffnet

• Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers Wird in neuem Tab/Fenster geöffnet

The Journal of Liquid Biopsy

• Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens Wird in neuem Tab/Fenster geöffnet

• Liquid biopsy: Cell-free DNA based analysis in breast cancer Wird in neuem Tab/Fenster geöffnet

• New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights Wird in neuem Tab/Fenster geöffnet

ESMO Podcasts

Listen to the most recent podcasts from the ESMO portfolio.

🎙️ ADCs in HER2+ metastatic breast cancer brain metastases - ESMO Podcasts Wird in neuem Tab/Fenster geöffnet

🎙️ Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer by ESMO Podcasts (soundcloud.com)

Oncology journal network

We’ll help you find the right home for your research – fast

Publishing your work can be time-consuming, especially if the first journal you submit to isn’t right for your research. With over 40 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters,  Elsevier’s Oncology Journal Network has the right home for your research. And with our transfer service, you’ll benefit from a smooth, simple publishing process.